"Depuis sa création en 1966, la Clinique des Cèdres a connu un fort développement. Avec une capacité de 603 lits et places dont 303 lits en Médecine-Chirurgie, 125 en Santé Mentale et 135 en Soins de Suite et Réadaptation, la Clinique des Cèdres est une des plus grandes clinique d’Europe. La Clinique des Cèdres est un établissement du groupe Ramsay Santé."

During the past decade, Clinique des Cèdres conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 3 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique des Cèdres" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 8 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials sponsored, "Centre Hospitalier Universitaire de Nīmes" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique des Cèdres" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Société Française d'Anesthésie et de Réanimation" with 2 trials as a collaborator, "Aysgarth Statistics" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Clinique des Cèdres" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Intensive Care Unit Syndrome" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Clinique des Cèdres" in a lesser frequency.

Most popular intervention types in "Clinique des Cèdres" are "Drug" (20 trials), "Other" (8 trials), "Device" (7 trials), "Procedure" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (3 trials), "Docetaxel" (2 trials), "Durvalumab" (2 trials), "FOLFIRI Protocol" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique des Cèdres" are 36 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique des Cèdres". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Clinique des Cèdres, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique des Cèdres, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".